National Healthcare financials
$224.16−0.80%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $408.0M | $381.8M | $386.5M | $382.7M | $374.9M | $373.7M | $369.4M | $340.2M | $300.7M | $297.2M | $300.9M | $288.5M |
| Gross profit | $408.0M | $381.8M | $386.5M | $382.7M | $374.9M | $373.7M | $369.4M | $340.2M | $300.7M | $297.2M | $300.9M | $288.5M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | $48.9M | $32.3M | $33.1M | $30.4M | $34.1M | $30.8M | $28.9M | $22.8M | $22.5M | $15.7M | $20.2M | $13.1M |
| Net income | $40.3M | $35.9M | $24.8M | $39.2M | $23.7M | $32.2M | $6.1M | $42.8M | $26.8M | $26.2M | $28.4M | $10.4M |
| Net margin | 9.9% | 9.4% | 6.4% | 10.3% | 6.3% | 8.6% | 1.6% | 12.6% | 8.9% | 8.8% | 9.4% | 3.6% |
| Diluted EPS | $2.54 | $2.27 | $1.58 | $2.50 | $1.52 | $2.07 | $0.39 | $2.73 | $1.73 | $1.69 | $1.83 | $0.68 |
| EBITDA | $60.1M | $43.9M | $44.9M | $41.5M | $45.1M | $41.7M | $40.4M | $33.4M | $31.9M | $26.3M | $20.2M | $23.2M |
| Operating cash flow | $43.3M | $62.5M | $16.8M | $66.2M | $62.8M | $39.3M | $12.8M | $34.2M | $50.7M | $9.6M | $25.7M | $32.3M |
| Free cash flow | $30.7M | $52.9M | $6.4M | $56.5M | $52.6M | $33.1M | $4.6M | $28.6M | $42.8M | $3.7M | $17.1M | $25.8M |
| Diluted shares | 15.9M | 15.8M | 15.7M | 15.7M | 15.6M | 15.6M | 15.7M | 15.7M | 15.6M | 15.5M | 15.5M | 15.3M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $39.2M | $85.5M | $92.8M | $130.6M | $111.0M | $90.4M |
| Short-term investments | $171.0M | $206.4M | $163.0M | $197.1M | $176.8M | $152.8M |
| Total debt | $0.00 | $0.00 | $40.0M | $73.1M | $110.0M | $134.0M |
| Total assets | $1.54B | $1.52B | $1.53B | $1.57B | $1.56B | $1.55B |
| Total liabilities | $408.9M | $427.5M | $451.9M | $513.9M | $536.8M | $540.8M |
| Shareholders' equity | $1.13B | $1.10B | $1.07B | $1.06B | $1.03B | $1.01B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology